The effect of omega-3 fatty acids on depressive symptoms and inflammatory markers in maintenance hemodialysis patients: a randomized, placebo-controlled clinical trial

[1]  D. Souza,et al.  Prevalence of depression symptoms and serum levels of interleukin‐6 in hemodialysis patients , 2014, Psychiatry and clinical neurosciences.

[2]  G. Parker,et al.  Fish oil as a management component for mood disorders – an evolving signal , 2013, Current opinion in psychiatry.

[3]  G. Ricevuti,et al.  Comparison between the AA/EPA ratio in depressed and non depressed elderly females: omega-3 fatty acid supplementation correlates with improved symptoms but does not change immunological parameters , 2012, Nutrition Journal.

[4]  A. Abdollahi,et al.  Relationship between a pro- and anti-inflammatory cytokine imbalance and depression in haemodialysis patients. , 2012, European cytokine network.

[5]  J. Martins,et al.  Eicosapentaenoic acid appears to be the key omega-3 fatty acid component associated with efficacy in major depressive disorder: a critique of Bloch and Hannestad and updated meta-analysis , 2012, Molecular Psychiatry.

[6]  W. Harris,et al.  Red blood cell fatty acids are associated with depression in a case-control study of adolescents. , 2012, Prostaglandins, leukotrienes, and essential fatty acids.

[7]  R. Stewart,et al.  Associations of polyunsaturated fatty acids with residual depression or anxiety in older people with major depression. , 2012, Journal of affective disorders.

[8]  R. Poland,et al.  Omega-3 Fatty Acid Augmentation of Citalopram Treatment for Patients With Major Depressive Disorder , 2012, Journal of clinical psychopharmacology.

[9]  M. Bloch,et al.  Omega-3 Fatty Acids for the Treatment of Depression: Systematic Review and Meta-Analysis , 2011, Molecular Psychiatry.

[10]  J. Buckley,et al.  Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial , 2011, British Journal of Nutrition.

[11]  J. Mann,et al.  Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression. , 2011, The Journal of clinical psychiatry.

[12]  K. Kalantar-Zadeh,et al.  Dietary omega-3 fatty acid, ratio of omega-6 to omega-3 intake, inflammation, and survival in long-term hemodialysis patients. , 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[13]  E. Toft,et al.  Marine n-3 polyunsaturated fatty acids in patients with end-stage renal failure and in subjects without kidney disease: a comparative study. , 2011, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[14]  Farshad Sharifi,et al.  The effect of low-dose omega 3 fatty acids on the treatment of mild to moderate depression in the elderly: a double-blind, randomized, placebo-controlled study , 2011, European Archives of Psychiatry and Clinical Neuroscience.

[15]  Y. Solak,et al.  Sertraline treatment is associated with an improvement in depression and health-related quality of life in chronic peritoneal dialysis patients , 2010, International Urology and Nephrology.

[16]  B. Baune,et al.  A psychoneuroimmunological review on cytokines involved in antidepressant treatment response , 2010, Human psychopharmacology.

[17]  P. Rogers,et al.  Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood. , 2010, The American journal of clinical nutrition.

[18]  M. Nowicki,et al.  Effect of intradialytic intravenous administration of omega-3 fatty acids on nutritional status and inflammatory response in hemodialysis patients: a pilot study. , 2009, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[19]  J. Martins.  EPA but Not DHA Appears To Be Responsible for the Efficacy of Omega-3 Long Chain Polyunsaturated Fatty Acid Supplementation in Depression: Evidence from a Meta-Analysis of Randomized Controlled Trials , 2009, Journal of the American College of Nutrition.

[20]  M. Fava,et al.  A double-blind, randomized controlled trial of ethyl-eicosapentaenoate for major depressive disorder. , 2009, The Journal of clinical psychiatry.

[21]  R. Bowden,et al.  Fish oil supplementation lowers C-reactive protein levels independent of triglyceride reduction in patients with end-stage renal disease. , 2009, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[22]  Z. Šumarac,et al.  Could depression be a new branch of MIA syndrome? , 2009, Clinical nephrology.

[23]  C. Eraldemir,et al.  Depressive Symptoms and Proinflammatory Cytokine Levels in Chronic Renal Failure Patients , 2008, Nephron Clinical Practice.

[24]  S. Keshavarz,et al.  Comparison of Therapeutic Effects of Omega-3 Fatty Acid Eicosapentaenoic Acid and Fluoxetine, Separately and in Combination, in Major Depressive Disorder , 2008, The Australian and New Zealand journal of psychiatry.

[25]  E. Shevach,et al.  Pro- and Anti-Inflammatory Cytokine Balance in Major Depression: Effect of Sertraline Therapy , 2008, Clinical & developmental immunology.

[26]  C. Saha,et al.  Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients--a pilot study. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[27]  Scott D. Cohen,et al.  Depression in end-stage renal disease patients: a critical review. , 2007, Advances in chronic kidney disease.

[28]  P. Caputi,et al.  Fish oil supplementation in the treatment of major depression: A randomised double-blind placebo-controlled trial , 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[29]  T. Ikizler,et al.  Gamma-tocopherol and docosahexaenoic acid decrease inflammation in dialysis patients. , 2007, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[30]  H. Uzun,et al.  Depression, Nutritional Status, and Serum Cytokines in Peritoneal Dialysis Patients: Is There a Relationship? , 2007, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[31]  S. Pljesa,et al.  Effect of n‐3 fatty acids on nutritional status and inflammatory markers in haemodialysis patients , 2007, Nephrology.

[32]  Z. Gluvić,et al.  Effects of N-3 PUFAs Supplementation on Insulin Resistance and Inflammatory Biomarkers in Hemodialysis Patients , 2007, Renal failure.

[33]  S. Chalon.  Omega-3 fatty acids and monoamine neurotransmission. , 2006, Prostaglandins, leukotrienes, and essential fatty acids.

[34]  L. Horrocks,et al.  Inhibitors of Brain Phospholipase A2 Activity: Their Neuropharmacological Effects and Therapeutic Importance for the Treatment of Neurologic Disorders , 2006, Pharmacological Reviews.

[35]  P. Kimmel,et al.  The predictive value of self-report scales compared with physician diagnosis of depression in hemodialysis patients. , 2006, Kidney international.

[36]  S. Moe,et al.  Review of the effects of omega-3 supplementation in dialysis patients. , 2006, Clinical journal of the American Society of Nephrology : CJASN.

[37]  Betül Kalender,et al.  Association of Depression with Markers of Nutrition and Inflammation in Chronic Kidney Disease and End-Stage Renal Disease , 2005, Nephron Clinical Practice.

[38]  E. Göka,et al.  IL‐6 levels decrease with SSRI treatment in patients with major depression , 2005, Human psychopharmacology.

[39]  Suzanne G. Watnick,et al.  Validation of 2 depression screening tools in dialysis patients. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[40]  M. Fava,et al.  PSYCHOSOCIAL FACTORS IN PATIENTS WITH CHRONIC KIDNEY DISEASE: Depression and Renal Disease , 2005, Seminars in dialysis.

[41]  E. Bosmans,et al.  Anti-Inflammatory Effects of Antidepressants Through Suppression of the Interferon-γ/Interleukin-10 Production Ratio , 2001, Journal of clinical psychopharmacology.

[42]  F. Finkelstein,et al.  Depression in chronic dialysis patients: assessment and treatment. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[43]  G. Kaysen,et al.  C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[44]  J. Hibbeln,et al.  Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy. , 1995, The American journal of clinical nutrition.

[45]  G. Rodin,et al.  The Beck Depression Inventory as a Screening Device for Major Depression in Renal Dialysis Patients , 1989, International journal of psychiatry in medicine.

[46]  J. Mann,et al.  Meta-analysis : Effects of Eicosapentaenoic Acid in Clinical Trials in Depression , 2013 .

[47]  K. Farrington,et al.  Depression in End‐Stage Renal Disease: Current Advances and Research , 2010, Seminars in dialysis.

[48]  P. Porcelli,et al.  Emotional symptoms, quality of life and cytokine profile in hemodialysis patients. , 2010, Clinical nephrology.

[49]  M. Fava,et al.  A Double-Blind Randomized Controlled Trial of Ethyl- Eicosapentaenoate (EPA-E) for Major Depressive Disorder , 2010 .

[50]  H. Chai,et al.  Efficacy of omega-3 fatty acids in mood disorders - a systematic review and metaanalysis. , 2009, Psychopharmacology bulletin.

[51]  P. Scully,et al.  Investigating the inflammatory phenotype of major depression: focus on cytokines and polyunsaturated fatty acids. , 2009, Journal of psychiatric research.

[52]  A. Sinclair,et al.  Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression , 2007, Lipids.

[53]  S. Pljesa,et al.  We-P14:469 The effect of N-3 fatty acids on nutritional status and inflammatory markers in hemodialysis patients , 2006 .

[54]  Habibollah Ghassemzadeh,et al.  Psychometric properties of a Persian‐language version of the Beck Depression Inventory ‐ Second edition: BDI‐II‐PERSIAN , 2005, Depression and anxiety.

[55]  Evon M. O. Abu-Taieh,et al.  Comparative Study , 2020, Definitions.